Shire Plans New Cinryze Versions, Promises Fresh M&A And Innovation
This article was originally published in The Pink Sheet Daily
Executive Summary
Shire ended 2013 on a high note with promises to keep up its fast but disciplined pace to generate strong profits and cash for use in fresh drug innovation and further M&A activity.